TABLE 2.
Comorbidities, Forrest classification, smoking and biochemical parameters
| H pylori (n=40) | NSAID use (n=43) | Combined H pylori and NSAID use (n=15) | P | |
|---|---|---|---|---|
| Associated diseases, n (%) | ||||
| None | 14 (35) | 5 (12) | 4 (27) | 0.02 |
| Diabetes mellitus II | 6 (15) | 3 (7) | – | |
| Hypertension | 3 (8) | 7 (16) | 3 (20) | |
| Osteoarthritis | 1 (3) | 8 (19) | 3 (20) | |
| Lupus | 3 (8) | 3 (7) | – | |
| Rheumatoid arthritis | – | 3 (7) | 1 (7) | |
| Others | 13 (33) | 14 (33) | 2 (13) | |
| Forrest classification (n) | ||||
| IA | 1 | – | – | NS |
| IB | 1 | 1 | 1 | |
| IIA | 1 | 2 | 3 | |
| IIB | 3 | 5 | 1 | |
| IIC | 7 | 3 | 2 | |
| III | 27 | 32 | 8 | |
| Smoking, n (%) | 8 (20) | 12 (28) | 3 (20) | NS |
| Hemoglobin (g/L) ± SD | 122±26 | 112±31 | 125±28 | NS |
| Platelets (×103/mL) ± SD | 211±130 | 262±183 | 257±156 | NS |
| Prothrombin time (s) ± SD | 14±9 | 12±3 | 11±2 | NS |
| Creatinine (μmol/L) ± SD | 97.24±61.88 | 106.08±123.76 | 75.2±35.36 | NS |
H pylori Helicobacter pylori; NS Not significant; NSAIDs Nonsteroidal anti-inflammatory drugs